PATIENT REPORTED OUTCOMES AND IMPROVEMENTS IN INTRAVAGINAL EJACULATORY LATENCY TIME IN DAPOXETINE-TREATED MEN WITH LIFELONG OR ACQUIRED PREMATURE EJACULATION: PHASE 3 POOLED ANALYSES